Skip to main content

Epocal, Procognia, Sense Proteomic, Abbott Laboratories, Luminex, Purdue University, Roche Diagnostics


Canadian Microarray Firm Gets VC Nod, Again

Epocal of Ottawa received CA $3.1 ($2.0) million in early-stage venture capital funding from Genesys Capital Partners. Genesys was the sole investor in the latest round, drawing funds from the New Generation Biotech Equity Fund, a labor-sponsored fund administered by Toronto-based Triax-Covington. The firm now has some $6.5 million invested in Epocal.

Epocal, founded by I-Stat founder Imants Lauks in 2001, develops sensor microarrays with fluidic circuits for DNA, cell, and protein assays targeting the genomic, diagnostic, and drug development markets.


Procognia Acquires Sense Proteomic

Procognia of Maidenhead, UK, has acquired protein chip manufacturer Sense Proteomic of Cambridge, UK, the companies announced. Financial details were not available.

Sense Proteomic’s staff will be integrated into Procognia and will remain at the Babraham Institute in Cambridge for at least another six months, according to a statement.

Procognia, which now has 60 employees, has developed technologies for the analysis of glycosylation patterns on proteins, which will be complemented by Sense’s functional array technology, the company said.

Procognia also said it closed a $4 million financing round from Apax Partners, Evergreen Partners, and Vitalife, bringing its total funding since its founding in April 2002 to $18.3 million.


Abbott Licenses Luminex Technology

Abbott Laboratories has entered two agreements for license, supply, and distribution rights to Luminex technology, Luminex said last week. Under the license agreement, Abbott will pay Luminex an upfront, non-refundable, license fee and royalties on commercialized assays and instruments. The related supply agreement covers the terms under which Abbott will purchase Luminex 100 systems and xMAP microspheres. Financial details were not disclosed.


Life Sciences Business Plan Competition

The Burton D. Morgan Center for Entrepreneurship at Purdue University and Roche Diagnostics are hosting a competition for life sciences business plans. Groups from academia, early-stage businesses, and established firms can compete for $100,000 in prize money and face-time with funders. Judging of eight finalists will be conducted on April 23 at Purdue.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.